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Abstract 
Objectives. Venous pressure measurement using an intravenous catheter is the sole method 
for the diagnosis of venous hypertension in patients with chronic venous insufficiency. A 
noninvasive tool to quantify increased venous pressure is essential for studying venous 
pathophysiology.  Aim of the study was to investigate the value of controlled compression 
ultrasound (CCU) for noninvasive assessment of venous pressure (VP) of the great saphenous 
vein (GSV) in healthy persons and patients with venous insufficiency to quantify venous 
hypertension. 
Methods. An optimal visible part of the GSV directly above the ankle was marked on the skin 
and compressed under ultrasound control and pressure needed for complete compression of the 
vein was recorded using a pressure manometer with a translucent silicone membrane. Complete 
insufficiency of the GSV (Hach IV) was documented by duplex ultrasound by an independent 
investigator before start of the study. VP measurement was performed while normal breathing, 
deep inspiration and expiration and during a standardized Valsalva maneuver.  
Results. Twenty controls and 19 patients with complete insufficiency of the GSV were included. 
Valsalva maneuver induced a slight increase in VP in controls (20.1 ± 4.5 vs 25.1 ± 6.6 mbar) 
but a significant higher increase in patients from 26 to 37 mbar (IQR 18.5-28.0 vs 31.5-43.0; p < 
0.001).  
Conclusion. Noninvasive venous pressure measurement of the great saphenous vein using 
CCU is feasible and documents an increased pressure during Valsalva maneuver in Hach IV 
patients compared to healthy controls. 
Keywords 
Chronic venous insufficiency, venous hypertension, noninvasive pressure measurement, 
compression ultrasound 
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Introduction 
Venous hypertension is the major pathophysiologic cause of symptoms in chronic venous 
insufficiency and responsible for microangiopathy and tissue alterations finally resulting in 
ulcerations.1-4 The evaluation of the microcirculatory status is challenging and time consuming.5,6 
The sole method for the quantification of venous pressure is intravasal acquisition with placing a 
needle in the dorsal vein of the foot.7  However, this ambulatory venous pressure measurement 
(AVPM), which is a widely accepted gold standard for the diagnosis of venous hypertension, is 
an invasive and sometimes painful technique.  A non-invasive and reliable tool to measure 
peripheral venous pressure under different conditions would be of great interest for further 
evaluation of pathophysiological mechanisms in venous disease and for studying new 
therapeutic options.  
Venous hypertension results in capillary hypertension, which is responsible for capillary leakage 
leading to edema and inflammation. The marked microangiopathy in patients with chronic 
venous insufficiency plays a crucial role in the development of trophic skin lesions (e.g. white 
atrophy, hyperpigmentation).8 Also in skin grafts of patients with venous ulcers, severe 
microcirculatory changes were described and were characterized by hypoxia and abnormal 
regeneration.9 Novel ultrasound techniques as contrast-enhanced ultrasound are on the way to 
characterize microcirculatory damage in different applications.10  
Recently, a novel ultrasound based technique for measuring venous pressure non-invasively 
was introduced.11  A combination of a pressure manometer with a translucent silicone 
membrane was used to measure the pressure needed to compress the vein completely, which 
was controlled by ultrasound.12   This method was validated at the cephalic vein at the forearm 
with excellent correlation compared to invasive intravenous pressure measurement (r = 0.95) 
within a range up to 70 cmH2O.12  Further studies using compression controlled ultrasound 
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(CCU) for central venous pressure measurement confirmed feasibility and reliability of this 
noninvasive technique.13,14  
We performed a prospective study to investigate the value of CCU for noninvasive assessment 
of venous pressure (VP) of the great saphenous vein (GSV) in healthy persons and patients with 
chronic venous insufficiency to quantify venous hypertension.  
Materials and Methods 
Study design 
This prospective study was performed at the two vascular centers of the university hospitals in 
Zurich and Bruderholz. Healthy volunteers without clinical signs or symptoms of chronic venous 
disease and without history of deep vein thrombosis were recruited for the control group in study 
center Zurich. Patients with known complete incompetence of the great saphenous vein (Hach 
IV) were recruited in both study centers. Exclusion criteria were history of deep vein thrombosis 
or past sclerotherapy or phlebectomy. Complete insufficiency of the GSV (Hach IV) was 
documented by duplex ultrasound by an independent investigator before start of the study. 
The study was approved by the local ethical committees of both study centers (KEK Zurich, EK-
1721 and EK beider Basel, EK 316/09). All participants gave their written informed consent. The 
study protocol was published at the Protocol Registration System ClinicalTrials.gov 
NCT01000909.  
Controlled compression ultrasound and venous pressure measurement 
Ultrasound imaging was performed with a high-end duplex ultrasound machine (iU22, Philips, 
Best, Netherlands) using a linear 17-5 MHz transducer.  SonoCT Real-time Compound Imaging 
(Philips) was used to optimize the B-Mode images and to suppress artifacts and focus position 
was adapted to the depth of the visible vein. Controls and patients were investigated in supine 
5 
 
position after a five minute rest in a temperature controlled vascular laboratory. The great 
saphenous vein was studied in a cross section B-mode image just above the medial ankle 
(Figure 1). After documentation of a satisfying image the point of measurement was marked on 
the skin with a waterproof marker.  Cross section vein diameter and venous pressure 
measurement was performed under four conditions: normal breathing, deep inspiration, deep 
expiration and Valsalva maneuver. The Valsalva maneuver was standardized by using a tube 
connected to a separate manometer.15 During Valsalva maneuver a constant pressure of 30 
mmHg had to be established by the subjects.  Venous pressure measurement was performed as 
described elsewhere.12  The GSV was compressed under ultrasound control and the pressure 
needed for complete compression of the vein was recorded by a pressure manometer with a 
translucent silicone membrane. VP was measured three times for each maneuver and the mean 
value was used for further analysis.  
Statistics 
Statistical analysis was made by using SPSS software version 20.0 (Statistical Package for the 
Social Science, IBM Corporation, Armonk, New York, USA) and was carried out in cooperation 
with the Division of Biostatistics at the Institute for Social and Preventive Medicine of the 
University of Zurich. Vein diameters showed to be normally distributed. Comparison of vein 
diameter within healthy controls and within Hach IV patients was done by paired sample test. 
Using the Bonferroni-correction a significance (2-tailed) of p < 0.01666 was considered as 
significant. To compare vein diameters of healthy controls with Hach IV patients independent 
sample tests including Bonferroni-correction were used by which significance (2-tailed) was 
accepted if p < 0.0125. 
VP in the group of the healthy subjects showed to be normally distributed. To analyze the values 
between the right and the left leg and between the maneuvers an ANOVA was calculated. After 
proving that there is no significant difference between the right and the left leg in healthy 
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subjects only pressure values of the right side were taken to compare with Hach IV patients. As 
pressure values of Hach IV subjects were not normally distributed data are expressed as median 
with interquartile ranges (IQR). Because VP in patients with Hach IV in both legs tend to be 
higher compared to patients with only one diseased leg, pressure values for comparison with 
healthy subjects were only taken from one leg per subject.  
To compare the increase of VP from normal breathing to Valsalva maneuver a quotient was 
calculated as follows: Quotient = (VPValsalva / VPnormal breathing) x 100 %. Comparison of VP between 
the groups was done by non-parametric, unpaired Mann-Whitney test. An asymptotic 
significance (2-tailed) p<0.05 was considered significant for all pressure analysis. 
 
Results 
Healthy subjects 
Twenty healthy volunteers (12 men) with a mean age of 31.0 years (range 18 - 64) were 
included. Mean body mass index (BMI) was 23.2 kg/m2 (range 19.5 - 29.0). Mean 
systolic/diastolic blood pressure was 115 / 67 mmHg (range 95 - 138 / 55 - 84) and mean heart 
rate was 67 beats per minute (range 48 - 115). 
Hach IV patients 
Nineteen patients (13 men, 25 legs) with a mean age of 53.0 years (range 24-75) and mean BMI 
29.1 kg/m2 (19.4 - 44.6) and with complete incompetence of the GSV (Hach IV) were included in 
the analysis. Mean systolic/diastolic blood pressure in this group was 137.8 / 83.9 mmHg (range 
117 - 176 / 70 - 105) and mean heart rate was 79 beats per minute (range 51-119). 
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GSV diameter in healthy subjects 
Mean diameter of the GSV was 2.6 mm (right leg) and 2.6 mm (left leg) in healthy controls at 
rest with a slight increase during deep inspiration (right leg: p = 0.185, left leg: p = 0.017; both 
n.s. with Bonferroni-correction) and expiration (right leg: p = 0.285, left leg: p = 0.034; both n.s. 
with Bonferroni-correction) and a significant increase (right and left leg: p < 0.001) during 
Valsalva maneuver to 2.9 mm (right) and 2.9 mm (left) respectively (Table 1). 
GSV diameter in Hach IV patients 
Mean diameter of the GSV in Hach IV legs was 3.8 mm with no significant increase during deep 
expiration and a significant increase during deep inspiration (p = 0.002) to 4.0 mm and Valsalva 
maneuver (p < 0.001) to 4.2 mm (Table 2). 
Comparison between GSV Diameter in healthy subjects and Hach IV patients 
GSV diameter in Hach IV patients showed to be significantly higher in each maneuver (normal 
breathing, maximum inspiration, maximum expiration or Valsalva maneuver) compared to vein 
diameters in healthy subjects (p < 0.001 for each comparison). 
Venous pressure in healthy subjects 
As shown in Table 1, in healthy controls there is no change of VP during normal breathing, 
maximum inspiration and maximum expiration. However, a significant difference (p < 0.001) was 
found between normal breathing and Valsalva, but no difference (p = 0.674) between the two 
legs was registered (Figure 2). 
Venous pressure in Hach IV patients 
The median and IQR of VP are displayed in Table 2. Similar to the healthy controls VP changed 
neither during normal breathing, nor after maximum inspiration and maximum expiration. VP 
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during normal breathing showed a significant lower value (p < 0.001) compared to Valsalva 
maneuver.  
Comparison between venous pressure in healthy subjects and Hach IV patients 
As mentioned above in patients with Hach IV in both legs only pressure values of the right leg 
were included to calculate potential differences to healthy controls. Statistical analysis showed 
no difference between the affected legs for normal breathing (p = 0.974) or Valsalva (p = 0.202). 
The diagram of the quotient between PVP during normal breathing and Valsalva is displayed in 
Figure 3. The median pressure augmentation in Hach IV patients is 61.6 % with an IQR of 30.9 – 
94.7 % while healthy controls showed a median pressure augmentation of 23.7 % with an IQR of 
7.3 – 36.3 %. Mann-Whitney test showed a highly significant increase (p < 0.001) of PVP values 
in Hach IV compared to healthy controls (Figure 2). 
Discussion 
In this study a novel non-invasive method for measuring venous pressure of the great 
saphenous vein was evaluated in healthy controls and patients with venous insufficiency. In 
contrast to AVPM in CCU there is no need for inserting an intravenous line into a dorsal foot 
vein. Venous pressure was investigated in different physiologic provocation maneuvers with 
reproducible and plausible pressure values. Valsalva maneuver induced only a slight increase in 
VP in healthy persons but a pronounced venous hypertension in insufficient veins. CCU is easy 
to learn and can be performed repeatedly under different conditions. It is therefore an ideal 
method to further study pathophysiology of venous hypertension without an invasive tool. 
Additional to the measurement of an elevated venous pressure, a parallel characterization of 
microcirculatory changes with contrast enhanced ultrasound may be very useful and is planned 
in ongoing studies. Venous hypertension, measured non-invasively, is a crucial but not the sole 
factor in microcirculatory damage in chronic venous insufficiency. Hemorheological parameters 
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are known to be a marker of venous hypertension in patients with venous disease and 
independent predictors of venous thromboembolism.16,17 Elevated vein pressures may also have 
an influence on transplanted flap microcirculation.18 
However, the study has some limitations. First, we did not compare venous pressure 
measurements with the gold standard AVPM to avoid patients’ discomfort by inserting a catheter 
in the dorsal foot vein. Our method has been validated at the cephalic vein with an excellent 
correlation compared to invasive intravenous pressure measurement.12  Second, blinding of the 
study was not possible due to the fact, that on ultrasound enlarged veins of Hach IV patients are 
easily visible to the investigator. The selection criterion of a complete valve insufficiency of the 
GSV was implemented to achieve a homogenous patient collective with comparable vascular 
pathology. The relatively small number of patients and controls do not legitimate to establish 
normal or cut-off values with this method. Further investigations in our vascular laboratory may 
lead to reliable standards.  
Conclusion 
Noninvasive venous pressure measurement of the great saphenous vein using controlled 
compression ultrasound is feasible and documents an increased pressure during Valsalva 
maneuver in Hach IV patients compared to healthy controls. This study is the basis to further 
evaluate therapeutic measures for chronic venous insufficiency regarding their effect on venous 
pressure.  
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Figure legends 
Figure 1: Non-invasive venous pressure measurement of the great saphenous vein at the ankle 
using a using a pressure manometer with a translucent silicone membrane. 
Figure 2: Venous pressure of the great saphenous vein in healthy controls and patients in supine 
position at rest and during Valsalva maneuver. 
Figure 3: Increase in venous pressure of the great saphenous vein during Valsalva maneuver in 
healthy controls and patients 
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Table 1 
Vein diameter (VD) and venous pressure (VP) of 20 healthy controls 
    
 Healthy controls 
 Right legs  Left legs 
 n = 20  n = 20 
VD [mm]    
    
Maneuver Mean (SD)  Mean (SD) 
Normal breathing 2.6 (0.9)  2.6 (0.9) 
Maximum inspiration 2.7 (0.9)  2.7 (0.9) 
Maximum expiration 2.7 (0.9)  2.7 (1.0) 
Valsalva 2.9 (0.9) *  2.9 (1.1) * 
    
VP [mbar]    
    
Maneuver Mean (SD)  Mean (SD) 
Normal breathing 20.1 (4.5)  21.2 (6.0) 
Maximum inspiration 21.9 (5.8)  22.8 (7.2) 
Maximum expiration 19.8 (5.1)  21.4 (6.3) 
Valsalva 25.1 (6.6) *  23.3 (6.1) * 
    
    
* P < 0.001 compared to normal breathing 
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Table 2 
Vein diameter (VD) and venous pressure (VP) of 19 patients 
  
 Patients 
 Hach IV legs 
  
VD [mm] n = 19 
  
Maneuver Mean (SD) 
Normal breathing 3.8 (0.9) 
Maximum inspiration 4.0 (0.9) * 
Maximum expiration 3.9 (0.8) 
Valsalva 4.2 (0.9) ** 
  
VP [mbar] n = 25 
  
Maneuver Median (IQR) 
Normal breathing 26 (18.5-28.0) 
Maximum inspiration 30 (23.5-34.5) 
Maximum expiration 24 (20.5-27.5) 
Valsalva 37 (31.5-43.0) ** 
  
  
* p = 0.002 and ** p < 0.001 compared to normal breathing 
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Figure 1 
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Figure 3 
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